Examining the Associations between Post-Stroke Cognitive Function and Common Comorbid Conditions among Stroke Survivors

Abstract

A considerable complication for stroke survivors is the subsequent development of cognitive decline or dementia. In this study, the relationship between the inflammation-centered comorbidity burden on post-stroke cognitive function among community-dwelling stroke survivors capable of independent living was examined. Data for this secondary analysis were collected from stroke survivors (n = 97) participating in a randomized clinical trial. Participants provided baseline responses, regarding cognitive function (mini-mental status exam, MMSE; Montreal cognitive assessment, MoCA), history of stroke comorbid conditions, and the Stroke Prognosis Instrument-II (SPI-II), an index of stroke comorbidity and recurrent stroke risk within the next two years. Relationships and differences between groups were tested for significance using Spearman’s correlation, Kruskal–Wallis, or Mann–Whitney U tests. Most stroke survivors (69%) had multiple comorbidities. Total SPI-II scores were negatively correlated to both MoCA and MMSE scores (r = −0.25, p = 0.01; r = −0.22, p = 0.03, respectively), and differences in MoCA scores among SPI-II risk groups (low, medium, high) were evident (p = 0.05). In contrast, there were no differences in MoCA or MMSE scores when comorbid conditions were examined individually. Lastly, no gender differences were evident in cognitive assessments. Our data support the premise that comorbidity’s burden impacts post-stroke cognitive decline, more than a single comorbid condition. Inflammation may be an important component of this comorbidity burden. Future studies that operationalize this concept will better illuminate the complex phenomenon of post-stroke cognitive decline for improved clinical rehabilitation modalities.

Cognitive Disorders in Post-Stroke Patients

“…Most respondents had comorbid hypertension (51.8%). The burden caused by various comorbid diseases (more than one) can reduce cognitive abilities in post-stroke patients (Morrison et al, 2022). Hypertension, diabetes mellitus, atrial fibrillation, and hypercholesterolemia can cause disorders of the blood vessels, which can damage brain structure and disrupt cerebral blood circulation, causing cognitive impairment in patients (Elendu et al, 2023).…”

Cardiac Biometrics and Perceived Workload Regression Analysis Using Random Forest Regressor in Cognitive Manufacturing Tasks

“…Cardiac problems could affect the readings of HR and HRV [37,38] . While stroke history had an impact to patient's cognitive function and abilities [39,40] . From 31 students interested to participate in the trial, 1 was eliminated due to their health condition.…”

Diagnosis of chemotherapy-related cognitive impairment

“…Jest to powszechnie stosowane w postępowaniu klinicznym i badaniach naukowych narzędzie do przesiewowego wykrywania zaburzeń poznawczych. Minibadanie stanu psychicznego (mini-mental state examination -MMSE), inaczej test Folsteina, dzięki temu że jego przeprowadzenie nie wymaga specjalnego sprzętu, przeszkolenia czy przygotowania pacjenta, może być wykonany w ciągu około pięciu minut w gabinecie lekarza czy przy łóżku chorego [10]. Minibadanie stanu psychicznego charakteryzuje się 18% czułością i 100% swoistością.…”